Author:
Kageyama Takahiro,Ikeda Kei,Tanaka Shigeru,Taniguchi Toshibumi,Igari Hidetoshi,Onouchi Yoshihiro,Kaneda Atsushi,Matsushita Kazuyuki,Hanaoka Hideki,Nakada Taka-Aki,Ohtori Seiji,Yoshino Ichiro,Matsubara Hisahiro,Nakayama Toshinori,Yokote Koutaro,Nakajima Hiroshi
Abstract
AbstractWe measured antibody responses in 2,015 healthcare workers who were receiving 2 doses of BNT162b2 mRNA vaccine against SARS-CoV-2. The vast majority (99.9%) had either seroconversion or a substantial increase in antibody titer. A multivariate linear regression model identified predictive factors for antibody responses which may have clinical implications.
Publisher
Cold Spring Harbor Laboratory